|
Current Challenges and New Opportunities in Follicular Lymphoma
STATEMENT OF NEED
Of the estimated 74,680 new cases of non-Hodgkin lymphoma each year in the United States, approximately 35% are follicular lymphoma (FL), an indolent, difficult-to-treat B-cell malignancy. Most patients are diagnosed at an average age of 65 years. Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrences with availab... |
|
|
Challenges and Opportunities in Hodgkin Lymphoma
STATEMENT OF NEED
Hodgkin lymphoma (HL) is a rare malignancy involving the lymph nodes and lymphatic system, with 8,500 new cases diagnosed and accounting for 1,050 deaths each year in the United States. In contrast with other cancers whose risk increases with age, the risk for HL increases in patients between 15 and 30 years of age, decreases during middle age, and is followed by another peak in adults older than 55. There are 2 main types of HL: classical HL, which accounts for 95% of cas... |
|
|
Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies
STATEMENT OF NEED
Although the clinical outcomes of patients with B-cell malignancies such as diffuse large B-cell lymphoma and B-cell acute lymphoblastic leukemia have improved during the past decade, many continue to develop relapsed or refractory disease, representing a significant cause of morbidity and mortality. CAR T-cell therapy has been shown to produce significant antitumor responses in these patients, for whom treatment options are limited. However, CAR T-cell therapy is associat... |
|
|
Improving Treatment Outcomes of Patients With Waldenstrom Macroglobulinemia
STATEMENT OF NEED
Waldenstrom macroglobulinemia (WM) is a rare lymphoproliferative disorder characterized by lymphoplasmacytic bone marrow infiltration and the presence of serum monoclonal IgM. With an estimated 1,500 new cases reported in the United States annually, the malignancy accounts for 2% of non-Hodgkin lymphomas. Unfortunately, WM is considered incurable with available therapies. Patients with low- and intermediate-risk disease have 5-year survival rates of 87% and 68%, respective... |
|
Virtual Patient: Adult Male with Reaction to Flying Hymenoptera Sting
This patient simulation involves an adult male who had a severe reaction to a flying hymenoptera sting. Based on the clinical history and test results, the learner will choose the best way to treat the patient with immunotherapy. The learner will answer specific questions that explain the immunotherapy treatment, including risks, intervals, duration, and possibility of relapse to the patient. The learner will receive feedback for each decision that is made, and numerous references that discuss... |
|
|
Crucial Conversations in Oncology Nursing: Management Considerations for the AML Patient
The landscape of AML treatment is evolving and newer targeted agents may improve outcomes for selected subgroups of patients. Oncology nursing professionals provide disease and treatment information, manage adverse effects, and offer emotional support. Knowledge of the key management issues for patients with AML is critical in fulfilling this role. Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and po... |
|
|
Opioid Use Disorder in Special Populations: Making Recovery a Goal
The opioid epidemic is ravaging many parts of the United States, resulting in drug overdose deaths emerging as the leading cause of injury death. The 2015 statistics from Health and Human Services on human and economic costs were staggering, reporting that 12.5 million people misused prescription opioids that year, resulting in $78.5 billion in economic costs. Yet the National Institute on Alcohol Abuse and Alcoholism (NIAA)'s National Epidemiological Survey on Alcohol Abuse and Related Condit... |
|
|
Looking at the Big Picture of IBD
The burden of inflammatory bowel diseases (IBD), of which Chroh's disease and ulcerative colitis are the primary entities, is significant and wide ranging. IBD that is not well-controlled impairs quality of life, social activities, travel and ability to work, leading to higher rates of absenteeism and permanent work disability.1,2 The idiopathic intestinal inflammation of IBD requires life-long treatment and accounts for enormous hospitalization costs. According to data from the U.S. Nationa... |
|
|
Getting to Remission: Differentiating Residual Symptoms from Treatment Side Effects in Major Depressive Disorder
Millions of US adults with MDD are inadequately treated despite the availability of effective therapies. Achieving and maintaining remission continues to be a considerable clinical challenge. In addition, cognitive impairment is a common residual symptom, and many clinicians are failing to assess for and manage this aspect of depression. Some residual symptoms, such as weight gain, sleep disturbances, and sexual dysfunction, may be difficult to distinguish from treatment side effects. Despite ... |
|
|
The Changing Landscape of IBD: Emerging Concepts in Patient Management
In the past 2 decades, the introduction of biologic therapies that target underlying disease processes has dramatically changed the treatment of the inflammatory bowel diseases (IBDs), ulcerative colitis and Crohn’s disease. Current biologic therapy with tumor necrosis factor inhibitors and anti-integrins has improved the treatment of IBD flares and maintenance of clinical remission. These agents are, however, limited by primary nonresponse and loss of response in a substantial proportion of... |
|
|
The Evolution of Multiple Myeloma Patient Management: Managing Today, Preparing for Tomorrow
The clinical multiple myeloma arena has undergone significant advances in diagnosis and prognosis, minimal residual disease monitoring, and supportive care. This expansion brings renewed hope to patients, but it presents new challenges for the clinicians charged with their care. Some patients enjoy many years in clinical remission, whereas for others survival is no more than 2 or 3 years. This reflects the heterogeneity of myeloma and underscores the inappropriateness of a one-size-fits-all ma... |
|
|
The Role that Gender Plays in Pain Perception, Treatment, and Addiction
Studies have shown that gender plays an important role in pain, pain perception, and opioid use. Women are more likely to gain access to opioids through their medical treatment. Not only are women prescribed opioids more often than men (53% vs. 46%), but this number increases with age. Often there is a lack of attention to underlying causes of opioid use disorder (OUD), particularly past sexual or emotional trauma, which can put women at a significantly higher risk for addiction and relapse. G... |
|
|
It Starts with a Signal: Understanding Pain, Addiction, and Treatment
The number of opioid related deaths in the US is on the rise and health care providers often struggle finding a balance between prescribing guidelines and the individual needs of patients with acute and/or chronic pain. It's imperative that clinicians seeing patients with pain are knowledgeable about acute and chronic pain pathways and underlying mechanisms so that they may appropriately assess and manage pain.
However, it can be difficult and daunting to evaluate patients with chronic pai... |
|
|
Treating B-Cell Lymphomas: Novel Agents and the Evolving State of Practice
Over the last several decades, advances in non-Hodgkin lymphoma (NHL) management have improved survival; however, relapse and the emergence of treatment-resistant NHL following standard therapy remain ongoing treatment challenges. With conventional therapy for B-cell NHL, response rates are suboptimal and many patients relapse, highlighting the need for novel treatments that address the risk of disease progression. Recently, several novel therapies—including small-molecule inhibitors of the ... |
|
|
Opioid Use Disorder in Special Populations: Making Recovery a Goal
The opioid epidemic is ravaging many parts of the United States, resulting in drug overdose deaths emerging as the leading cause of injury death. The 2015 statistics from Health and Human Services on human and economic costs were staggering, reporting that 12.5 million people misused prescription opioids that year, resulting in $78.5 billion in economic costs. Yet the National Institute on Alcohol Abuse and Alcoholism (NIAA)'s National Epidemiological Survey on Alcohol Abuse and Related Condit... |
|
|
Finding Feeling: Treating Traumatic Dissociation
Trauma is a both a physical and psychological disruption, a discontinuity in experience. The helplessness associated with it challenges a person’s sense of agency and therefore their customary control over mind and body. Dissociative disorders constitute a failure of integration of identity, memory, or consciousness, andmost often occur in the aftermath of trauma. A Dissociative Subtype has been added to the diagnosis of Post-Traumatic Stress Disorder the DSM-5. This requires all of the DSM-... |
|
|
A 4-Year Prospective Study of Eating Disorder NOS
To examine the course of Eating Disorder NOS (EDNOS) compared with anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorder (BED). Method: Prospective study of 385 participants meeting DSM-IV criteria for AN, BN, BED and EDNOS at 3 sites. Recruitment was from the community and specialty clinics. Participants were followed at 6-month intervals over a 4-year period using the Eating Disorder Examination as the primary assessment. Results: EDNOS remitted significantly more quickly tha... |
|
|
Separation Anxiety in Children & Adolescents
This CE test is based on the book "Separation Anxiety in Children & Adolescents" (2005, 298 pages). The book presents a research-based approach to understanding the challenges of separation anxiety and helping children, adolescents, and their parents build the skills they need to overcome it. The authors provide step-by-step guidelines for implementing the entire process of therapy-from intake and assessment through coping skills training, cognitive-behavioral interventions, and relapse preven... |
|
|
Substance Abuse and Dependency
Target audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors
This course looks at the assessment and treatment of a variety of drug and alcohol related issues as well as an in-depth look at the behavioral and physiological effects of some of the most commonly abused drugs.
Reading of the books, "Treating Alcohol and Drug Problems in Psychotherapy Practice" and "Buzzed: The Straight Facts about the Most Used and Abused Drugs from Alcohol t... |
|
|
Substance Abuse Treatment: Addressing the Specific Needs of Women
Target Audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors
Course Syllabus:
* Introduction
* Patterns of Use: From Initiation to Treatment
* Substance Use and Birth Outcomes
* Culturally Responsive Screening and Assessment
* The Impact of Trauma and Prenatal Care
* Substance Abuse Among Specific Population Groups
* Relational Model Approach
* Postpartum Relapse Prevention |
|
|
Tobacco use and mental illness
Overview of contributing factors to the increased use of tobacco amongst individuals with mental illness.
Target audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors
Syllabus:
* Tobacco use & mental illness
* Assessment & intervention
* Smoking cessation
* Relapse prevention
Unlimited Access to Over 200 Courses
Starting at Only $74.99 |
|
|
Introduction and Overview (Section I); and The Older Adult Treatment Population (Section II): From Substance Abuse Relapse Prevention for Older Adults--A Group Treatment Approach
I. Introduction and Overview: From Substance Abuse Relapse Prevention for Older Adults—A Group Treatment Approach provides background and how-to directions for introducing relapse techniques to older clients.
II. The Older Adult Treatment Population: From Substance Abuse Relapse Prevention for Older Adults—A Group Treatment Approach provides an overview of the target population for cognitive-behavioral and self-management intervention (CB/SM) for older adults who have substance use diso... |
|
|
Codependency: Causes, Consequences and Cures
In this course, the author offers in-depth and in-person strategies for therapists to use in working with clients who present with the characteristic behavior patterns of codependency. Clients are usually unaware of the underlying codependency that is often responsible for the symptoms they’re suffering. Starting with emphasis on the delicate process of building a caring therapeutic relationship with these clients, the author guides readers through the early shame-inducing parenting styles t... |
|